Sign up here and take full advantage of MicrobiomePost‘s features.
Sign up

Live Biotherapeutics as cancer treatments: scientific and regulatory challenges

Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.

During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiomepost sat down with Jean-Luc Marsat, CEO & Chairman at EverImmune, to discuss the research EverImmune carries out in oncology.

Most recent

HCPs Area

Industry

MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome

Published by Clorofilla Srl

Facebook-f Linkedin Twitter Youtube
© 2016-2023 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy